NCT02865837CompletedNot Applicable
Effect of Bladder Distension on Organs at Risk Doses in PDR 3D Image-guided Brachytherapy of Cervical Cancer
Institut de Cancérologie de Lorraine2 sites in 1 country22 target enrollmentStarted: September 1, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 22
- Locations
- 2
- Primary Endpoint
- Demonstrate the non inferiority of 3D image-guided brachytherapy with emptied bladder compared to filled bladder for the dose received by the bladder
Study Overview
Brief Summary
The purpose of this study is to compare, for each patient, dosimetry of organs at risk (bladder, rectum, sigmoid, small bowel) in two bladder distension procedures (emptied by a urinary catheter or filled with 120cc) during PDR 3D image-guided brachytherapy of cervical cancer.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age > or = 18 years old
- •with a cervical cancer histologically proven (squamous cell carcinoma, adenocarcinoma and neuroendocrine cell carcinoma)
- •Utero-vaginal brachytherapy indications::
- •Stage 1B1: brachytherapy before surgery
- •Stages IB2 to IIIB: after pelvic radiotherapy (45Gy/25 fractions/5 weeks) with or without concomitant chemotherapy
- •Ability to provide an informed written consent form
- •Patient must be affiliated to a social security system
Exclusion Criteria
- •Age < 18 years old
- •History of pelvic radiotherapy
- •History of pelvic surgery
- •Recent joint prothesis (<3 months)
- •Pregnant woman or being breastfeeding
- •Patients deprived of liberty or under supervision
Outcomes
Primary Outcomes
Demonstrate the non inferiority of 3D image-guided brachytherapy with emptied bladder compared to filled bladder for the dose received by the bladder
Time Frame: 1 day
Difference of the maximum dose received by 2 cm3 bladder (D2cc) between the two conditions: full and empty.
Secondary Outcomes
- Non-inferiority based on the dose received by the rectum(1 day)
- Non-inferiority based on the dose received by the small bowel(1 day)
- Body Mass Index(1 day)
- Non-inferiority based on the dose received by the sigmoid(1 day)
- FIGO staging system(1 day)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Unknown
Not Applicable
Salvage Radiotherapy After Radical ProstatectomyProstate CancerNCT02597725University of Aarhus70
Completed
Not Applicable
Relationship Between Bladder Distention and Hysteroscopy ApplicationMenorrhagiaNCT01848847Namik Kemal University102
Completed
Not Applicable
The effect of reduced catheter-related bladder discomfort by intraoperative dexmedetomidine on postoperative pain sensation in patient undergoing microdiscectomyKCT0002369Hallym University Medical Center- Chuncheon76
Completed
Not Applicable
Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial CystitisInterstitial Cystitis, ChronicPainful Bladder SyndromeNCT03069053Fondazione IRCCS Policlinico San Matteo di Pavia57
Unknown
Not Applicable
Efficacy of Reduction of the Balloon Volume for Prevention of Postoperative Catheter-related Bladder Discomfort in Patients Undergoing Non-lower Urinary Tract SurgeryCatheter-Related Bladder DiscomfortUrinary CatheterNCT06038448Buddhist Tzu Chi General Hospital120
